|Bid||1.4600 x 1300|
|Ask||1.4700 x 800|
|Day's Range||1.4650 - 1.4900|
|52 Week Range||1.3000 - 3.1400|
|Beta (5Y Monthly)||1.58|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 09, 2021 - Nov 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on Thursday, October 7, 2021 at 3:30pm ET.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest®, announced today revenues for the second quarter of 2021 increased 125% from the same period a year ago, and are up 82% sequentially. Year to date, revenues have increased 130% from the same period last year. The growth is driven by continued adoption of ContraPest across its key market segments an